Bio-Rad to Participate in Upcoming Investor Conferences

Bio-Rad to Participate in Upcoming Investor Conferences

BIO-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company will participate in the following upcoming investor conferences:

2026 RBC Capital Markets Global Healthcare Conference
Format: Fireside chat and one-on-one investor meetings
Participants: Roop K. Lakkaraju, Chief Financial Officer
Date and Time: Tuesday, May 19, 2026, at 8:30 AM Eastern Time; a live webcast and subsequent replay of the fireside chat event will be available in the Investor Relations section of Bio-Rad's website at bio-rad.com

Jefferies 2026 Global Healthcare Conference
Format: Fireside chat and one-on-one investor meetings
Participants: Roop K. Lakkaraju, Chief Financial Officer
Date and Time: Wednesday, June 3, 2026 at 8:45 AM Eastern Time; a live webcast and subsequent replay of the fireside chat event will be available in the Investor Relations section of Bio-Rad's website at bio-rad.com

About Bio-Rad

BIO-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, BIO-Rad operates a global network of research, development, manufacturing, and sales operations with over 7,400 employees, and $2.6 billion in revenues in 2025. Our customers include universities, research institutions, hospitals, and biopharmaceutical companies, as well as clinical, food safety and environmental quality laboratories. Together, we develop innovative, high-quality products that advance science and save lives. To learn more, visit bio-rad.com .

Investor Contact:
Ruben Argueta, Investor Relations
510-741-6104
ir@bio-rad.com

Media Contact:
Anna Gralinska, Corporate Communications
510-741-6643
cc@bio-rad.com

News Provided by Business Wire via QuoteMedia

BIO
The Conversation (0)
Lexaria Updates Financial Position

Lexaria Updates Financial Position

KELOWNA, BC / ACCESS Newswire / September 17, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is providing the following update.Lexaria is in a strong cash position following both its recently announced Australian tax... Keep Reading...
Cespira, the Joint Venture between Westport and Volvo Group, reveals how HPDI 3.0 advances fuel economy and expands OEM options

Cespira, the Joint Venture between Westport and Volvo Group, reveals how HPDI 3.0 advances fuel economy and expands OEM options

Westport Fuel Systems Inc. ("Westport") (TSX:WPRT Nasdaq: WPRT), today announced Cespira, its joint venture with Volvo Group, released new technical details of HPDIâ„¢ 3.0, the next generation of its proven High Pressure Direct Injection fuel system. HPDI 3.0 retains proven HPDI combustion... Keep Reading...
Lexaria Announces Closing of Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds

Lexaria Announces Closing of Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds

KELOWNA, BC / ACCESS Newswire / September 9, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today closed its previously announced exercise of certain outstanding warrants to purchase an aggregate of 453,969 shares of the... Keep Reading...
Lexaria Announces Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds

Lexaria Announces Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds

KELOWNA, BC / ACCESS Newswire / September 8, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to... Keep Reading...
Lexaria to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Lexaria to Present at the H.C. Wainwright 28th Annual Global Investment Conference

KELOWNA, BC / ACCESS Newswire / September 4, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or the "Company"), a global innovator in oral drug delivery platforms, announces that it will participate in the 28th Annual H.C. Wainwright Global Investment Conference, taking place September... Keep Reading...

Interactive Chart

Latest Press Releases

Related News